NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
177 hedge funds and large institutions have $1.63B invested in NEVRO CORP. in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 27 closing their positions.
7% more capital invested
Capital invested by funds: $1.52B → $1.63B (+$113M)
4% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 27
1% more funds holding
Funds holding: 176 → 177 (+1)
3% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 60
11% less call options, than puts
Call options by funds: $29.1M | Put options by funds: $32.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$150M |
| 2 |
Millennium Management
New York
|
+$13.1M |
| 3 |
JP Morgan Chase
New York
|
+$10.3M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.28M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$30.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$22.8M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$20.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$17.8M |
NVRO Hedge Fund Activity: Q3 2022 in Review
177 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2022, worth a combined $1.63B — up 7.5% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NVRO positions and 27 closed out — a net gain of 1 holder — while 58 added to existing stakes and 60 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $150M. The largest seller was T. Rowe Price Associates, cutting an estimated $33.8M.
- 177 institutional investors held NEVRO CORP. (NVRO) as of Q3 2022, up from 176 in Q2 2022.
- Funds reported $1.63B of NEVRO CORP. stock for Q3 2022, up 7.5% quarter-over-quarter.
- 28 funds opened new NEVRO CORP. positions in Q3 2022 and 27 closed out, a net change of +1 holder.
- The largest NEVRO CORP. buyer in Q3 2022 was Fidelity Investments, an estimated $150M added.
- The largest NEVRO CORP. seller in Q3 2022 was T. Rowe Price Associates, an estimated $33.8M sold.
Based on aggregated 13F filings for Q3 2022.